Vineti Tessa partner to advance cancer immunotherapies

Vineti, Tessa partner to advance cancer immunotherapies

06:08 EST 23 Nov 2018 | Pharmaceutical Business Review

Tessa Therapeutics (Tessa), an international clinical stage biopharmaceutical company focusing on cellular immunotherapy treatments for cancer, is a leading developer of personalized T cell therapies for solid tumors,

The post Vineti, Tessa partner to advance cancer immunotherapies appeared first on Pharmaceutical Business review.

Original Article: Vineti, Tessa partner to advance cancer immunotherapies

More From BioPortfolio on "Vineti, Tessa partner to advance cancer immunotherapies"